Skip to main content
profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptions

Repligen Corporation News

10 must-know biotech stock events to close out 2016

Important clinical trial results in Alzheimer's, cancer and Crohn's disease and a big FDA decision for Sarepta are expected before the end of the year.

Trade-Ideas: Repligen (RGEN) Is Today's Weak On High Relative Volume Stock

Trade-Ideas LLC identified Repligen (RGEN) as a weak on high relative volume candidate

Today's Dead Cat Bounce Stock Is Repligen (RGEN)

Trade-Ideas LLC identified Repligen (RGEN) as a "dead cat bounce" (down big yesterday but up big today) candidate

Insider Trading Alert - RGEN, DVA And FLT Traded By Insiders

Stocks with insider trader activity include RGEN, DVA and FLT

Trade-Ideas: Repligen (RGEN) Is Today's New Lifetime High Stock

Trade-Ideas LLC identified Repligen (RGEN) as a new lifetime high candidate

Breaking News

BP Among Leaders of Fair Value Increases by Morningstar

In the energy sector, 25% of the companies covered by Morningstar garnered fair-value increases of more than 10%.

How to Purge Gun Stocks From Your 401(k)

After mass shootings, a lot of investors are saying enough if enough.

Nvidia Stock: Investors Are Buying the Dip. Where From Here?

Nvidia stock is being bought on the dip. Here's how traders should approach it now.

Broadcom Agrees to Buy VMware in $61 Billion Cash-and-Stock Cloud Software Deal

"Combining our assets and talented team with Broadcom's existing enterprise software portfolio creates a remarkable enterprise software player," said VMware CEO Raghu Raghuram.